Investor Relations

Home
Investor Relations
Important Notice

Announcement

The Company and BeOne Medicines announced a clinical supply agreement to evaluate CX-5461 in combination with tislelizumab in advanced solid tumor

Download

Dec: 11; 2025

Senhwa Biosciences, Inc. will attend the institutional investor conference invited by Cathay Securities Corporation.

1.Date of institutional investor conference:2025/12/23
2.Time of institutional investor conference: 14:00 (Taiwan time)
3.Location of institutional investor conference: 18F, No. 333, Sec. 2, Dunhua S. Rd., Da'an Dist., Taipei City, Taiwan(Cathay Securities Headquarters)
4.Outline of institutional investor conference: The Company will attend Cathay Securities' investor conference to update the Company's business operations.
5.Any other matters that need to be specified: None. Related information will be disclosed on MOPS

Dec: 17; 2025